心臟瓣膜市场规模、份额和成长分析（按类型、地点、治疗方法、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，全球心臟瓣膜市场规模将达到 95.8 亿美元，到 2025 年将达到 106.7 亿美元，到 2033 年将达到 253.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 11.4%。

全球心臟瓣膜市场正经历变革时期，其驱动力主要来自心血管疾病（尤其是心臟衰竭）治疗技术的进步。随着心臟病盛行率的上升，人们越来越关注能够改善治疗效果的创新解决方案。主要产业参与者推出的尖端产品将改善治疗调查方法并推动进一步发展，预计该市场将显着成长。全球心血管疾病患者人数的不断增加是这项扩张的关键因素。瓣膜疾病和冠状动脉疾病发生率的上升正在推动对心臟瓣膜置换术对于恢復最佳心臟功能和改善患者整体预后至关重要。

全球心臟瓣膜市场成长要素

全球心臟瓣膜市场的成长主要受人口老化和久坐生活方式趋势的驱动。这些因素导致心臟瓣膜疾病的盛行率不断上升，增加了对有效治疗方法的需求。心臟瓣膜设计和手术技术的进步也是推动该市场发展的关键因素。此外，微创手术方案的日益普及进一步提高了人们对心臟瓣膜疾病手术治疗的认知度和接受度，缩短了患者的復健时间，改善了整体治疗效果。

全球心臟瓣膜市场面临的限制因素

全球心臟瓣膜市场面临严峻挑战，这主要归因于各国政府对医疗产品（尤其是心臟瓣膜）的研发、生产和应用实施的严格监管。这些法规结构要求流程复杂且耗时，需要进行广泛的测试并提交详尽的文檔，以确保器械的安全性和有效性。这种高度严格的审查可能会抑制创新并减缓市场成长，因为製造商必须投入大量时间和资源来满足合规要求，而且核准流程也可能出现延误。因此，这种监管环境有可能阻碍新型心臟瓣膜解决方案的及时上市。

全球心臟瓣膜市场趋势

由于心臟瓣膜疾病盛行率不断上升，以及技术进步催生出创新型心臟瓣膜装置，全球心臟瓣膜市场正经历显着成长。大量患者面临诸如风湿性心臟病等可能导致严重併发症的疾病，这加速了对有效治疗方案的需求。此外，获得监管部门核准的新型改良装置不断涌现，为製造商创造了机会，加剧了市场竞争，并推动了产品品质和疗效的提升。这些因素共同造就了一个不断扩张且充满活力的市场，旨在满足全球迫切的医疗需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球心臟瓣膜市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 经导管心臟瓣膜
• 生物瓣膜
• 机械心臟瓣膜
• 其他的

全球心臟瓣膜市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 二尖瓣
• 主动脉瓣
• 其他部分

全球心臟瓣膜市场规模（依治疗方法划分）及复合年增长率（2026-2033 年）

• 心臟瓣膜修復
• 心臟瓣膜置换术

全球心臟瓣膜市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 心臟研究所
• 医院和诊所
• 专业中心
• 其他的

全球心臟瓣膜市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Medtronic（Ireland）
• Edwards Lifesciences（United States）
• Boston Scientific（United States）
• Abbott Laboratories（United States）
• LivaNova（United Kingdom）
• CryoLife（United States）
• MicroPort Scientific（China）
• Braile Biomedica（Brazil）
• TTK Healthcare（India）
• Colibri Heart Valve（United States）
• Venus Medtech（China）
• Peijia Medical（China）
• Lepu Medical Technology（China）
• Meril Life Sciences（India）
• Biotronik（Germany）
• Neovasc（Canada）
• Cardiac Dimensions（United States）
• HighLife Medical（France）
• Mardil Medical（United States）

结论与建议

Global Cardiac Valve Market size was valued at USD 9.58 Billion in 2024 and is poised to grow from USD 10.67 Billion in 2025 to USD 25.31 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The global cardiac valve market is undergoing a transformative phase driven by technological advancements in the management of cardiovascular diseases, particularly heart failure. As the prevalence of cardiac conditions rises, there is a heightened focus on innovative solutions to improve treatment outcomes. The market is poised for significant growth, propelled by the introduction of cutting-edge products from major industry players, which will enhance treatment methodologies and drive further advancements. A critical factor in this expansion is the increasing global population affected by various cardiovascular issues. The growing incidence of conditions such as valvular disorders and coronary artery disease has led to a heightened demand for cardiac valve replacements, which are essential in restoring optimal cardiac function and improving overall patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Valve market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Valve Market Segments Analysis

Global Cardiac Valve Market is segmented by Type, Position, Treatment, End User and region. Based on Type, the market is segmented into Trans-Catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve and Others. Based on Position, the market is segmented into Mitral Valve, Aortic Valve and Other Position. Based on Treatment, the market is segmented into Cardiac Valve Repair and Cardiac Valve Replacement. Based on End User, the market is segmented into Cardiac Research Institute, Hospital and Clinics, Speciality centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Valve Market

The growth of the global cardiac valve market is primarily fueled by the rising elderly population and a trend toward more sedentary lifestyles. These factors contribute to a higher prevalence of heart valve diseases, intensifying the demand for effective treatments. Technological advancements in heart valve design and procedures also play a crucial role in driving this market forward. Additionally, there is an increasing emphasis on minimally invasive surgical options, which enhances patient recovery times and overall outcomes, further encouraging awareness and acceptance of surgical interventions in the management of heart valve issues.

Restraints in the Global Cardiac Valve Market

The Global Cardiac Valve market faces significant challenges stemming from stringent government regulations that oversee the development, production, and application of medical products, particularly cardiac valves. These regulatory frameworks demand a complex and labor-intensive process that requires extensive testing and comprehensive documentation to ensure the safety and efficacy of these devices. This high level of scrutiny can impede innovation and slow down the market's growth, as manufacturers must allocate considerable time and resources to meet compliance requirements while also dealing with potential delays in the approval process. Consequently, this regulatory landscape can hinder the timely availability of new cardiac valve solutions.

Market Trends of the Global Cardiac Valve Market

The Global Cardiac Valve market is witnessing substantial growth driven by a combination of rising prevalence of heart valve diseases and advancements in technology that yield innovative cardiac valve devices. As a significant number of individuals face conditions such as rheumatic heart disease, which can lead to severe complications, the demand for effective treatment solutions is accelerating. Additionally, the emergence of new, enhanced devices that receive regulatory approvals is creating opportunities for manufacturers, fostering competition and driving improvements in quality and efficacy. This confluence of factors highlights a dynamic market poised for expansion, aimed at addressing urgent healthcare needs globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Cardiac Valve Market Size by Type & CAGR (2026-2033)

• Market Overview
• Trans-Catheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve
• Others

Global Cardiac Valve Market Size by Position & CAGR (2026-2033)

• Market Overview
• Mitral Valve
• Aortic Valve
• Other Position

Global Cardiac Valve Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Cardiac Valve Repair
• Cardiac Valve Replacement

Global Cardiac Valve Market Size by End User & CAGR (2026-2033)

• Market Overview
• Cardiac Research Institute
• Hospital and Clinics
• Speciality centers
• Others

Global Cardiac Valve Market Size & CAGR (2026-2033)

• North America (Type, Position, Treatment, End User)
  • US
  • Canada
• Europe (Type, Position, Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Position, Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Position, Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Position, Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Dimensions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HighLife Medical (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mardil Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations